TABLE OF CONTENTS

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Antiepileptic Drugs Market Segmentation, By Drug Generation
8.1 First Generation
8.2 Second Generation
8.3 Third Generation

9. Antiepileptic Drugs Market Segmentation, By Distribution Channel
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies
9.4 Drug Store

10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Antiepileptic Drugs Market, by Country
10.2.2North America Antiepileptic Drugs Market, By Drug Generation
10.2.3 North America Antiepileptic Drugs Market, By Distribution Channel
10.2.4 USA
10.2.4.1 USA Antiepileptic Drugs Market, By Drug Generation
10.2.4.2 USA Antiepileptic Drugs Market, By Distribution Channel
10.2.5 Canada
10.2.5.1 Canada Antiepileptic Drugs Market, By Drug Generation
10.2.5.2 Canada Antiepileptic Drugs Market, By Distribution Channel
10.2.6 Mexico
10.2.6.1 Mexico Antiepileptic Drugs Market By Drug Generation
10.2.6.2 Mexico Antiepileptic Drugs Market By Distribution Channel
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Antiepileptic Drugs Market by Country
10.3.1.2 Eastern Europe Antiepileptic Drugs Market By Drug Generation
10.3.1.3 Eastern Europe Antiepileptic Drugs Market By Distribution Channel
10.3.1.4 Poland
10.3.1.4.1 Poland Antiepileptic Drugs Market By Drug Generation
10.3.1.4.2 Poland Albumin By Distribution Channel
10.3.1.5 Romania
10.3.1.5.1 Romania Antiepileptic Drugs Market By Drug Generation
10.3.1.5.2 Romania Antiepileptic Drugs Market By Distribution Channel
10.3.1.6 Hungary
10.3.1.6.1 Hungary Antiepileptic Drugs Market By Drug Generation
10.3.1.6.2 Hungary Antiepileptic Drugs Market By Distribution Channel
10.3.1.7 Turkey
10.3.1.7.1 Turkey Antiepileptic Drugs Market By Drug Generation
10.3.1.7.2 Turkey Antiepileptic Drugs Market By Distribution Channel
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Antiepileptic Drugs Market By Drug Generation
10.3.1.8.2 Rest of Eastern Europe Antiepileptic Drugs Market By Distribution Channel
10.3.2 Western Europe
10.3.2.1 Western Europe Antiepileptic Drugs Market by Country
10.3.2.2 Western Europe Antiepileptic Drugs Market By Drug Generation
10.3.2.3 Western Europe Antiepileptic Drugs Market By Distribution Channel
10.3.2.4 Germany
10.3.2.4.1 Germany Antiepileptic Drugs Market By Drug Generation
10.3.2.4.2 Germany Antiepileptic Drugs Market By Distribution Channel
10.3.2.5 France
10.3.2.5.1 France Antiepileptic Drugs Market By Drug Generation
10.3.2.5.2 France Antiepileptic Drugs Market By Distribution Channel
10.3.2.6 UK
10.3.2.6.1 UK Antiepileptic Drugs Market By Drug Generation
10.3.2.6.2 UK Antiepileptic Drugs Market By Distribution Channel
10.3.2.7 Italy
10.3.2.7.1 Italy Antiepileptic Drugs Market By Drug Generation
10.3.2.7.2 Italy Antiepileptic Drugs Market By Distribution Channel
10.3.2.8 Spain
10.3.2.8.1 Spain Antiepileptic Drugs Market By Drug Generation
10.3.2.8.2 Spain Antiepileptic Drugs Market By Distribution Channel
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Antiepileptic Drugs Market By Drug Generation
10.3.2.9.2 Netherlands Antiepileptic Drugs Market By Distribution Channel
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Antiepileptic Drugs Market By Drug Generation
10.3.2.10.2 Switzerland Antiepileptic Drugs Market By Distribution Channel
10.3.2.11 Austria
10.3.2.11.1 Austria Antiepileptic Drugs Market By Drug Generation
10.3.2.11.2 Austria Antiepileptic Drugs Market By Distribution Channel
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Antiepileptic Drugs Market By Drug Generation
10.3.2.12.2 Rest of Western Europe Antiepileptic Drugs Market By Distribution Channel
10.4 Asia-Pacific
10.4.1 Asia Pacific Antiepileptic Drugs Market by Country
10.4.2 Asia Pacific Antiepileptic Drugs Market By Drug Generation
10.4.3 Asia Pacific Antiepileptic Drugs Market By Distribution Channel
10.4.4 China
10.4.4.1 China Antiepileptic Drugs Market By Drug Generation
10.4.4.2 China Antiepileptic Drugs Market By Distribution Channel
10.4.5 India
10.4.5.1 India Antiepileptic Drugs Market By Drug Generation
10.4.5.2 India Antiepileptic Drugs Market By Distribution Channel
10.4.6 Japan
10.4.6.1 Japan Antiepileptic Drugs Market By Drug Generation
10.4.6.2 Japan Antiepileptic Drugs Market By Distribution Channel
10.4.7 South Korea
10.4.7.1 South Korea Antiepileptic Drugs Market By Drug Generation
10.4.7.2 South Korea Antiepileptic Drugs Market By Distribution Channel
10.4.8 Vietnam
10.4.8.1 Vietnam Antiepileptic Drugs Market By Drug Generation
10.4.8.2 Vietnam Antiepileptic Drugs Market By Distribution Channel
10.4.9 Singapore
10.4.9.1 Singapore Antiepileptic Drugs Market By Drug Generation
10.4.9.2 Singapore Antiepileptic Drugs Market By Distribution Channel
10.4.10 Australia
10.4.10.1 Australia Antiepileptic Drugs Market By Drug Generation
10.4.10.2 Australia Antiepileptic Drugs Market By Distribution Channel
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Antiepileptic Drugs Market By Drug Generation
10.4.11.2 Rest of Asia-Pacific Antiepileptic Drugs Market By Distribution Channel
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Antiepileptic Drugs Market by Country
10.5.1.2 Middle East Antiepileptic Drugs Market By Drug Generation
10.5.1.3 Middle East Antiepileptic Drugs Market By Distribution Channel
10.5.1.4 UAE
10.5.1.4.1 UAE Antiepileptic Drugs Market By Drug Generation
10.5.1.4.2 UAE Antiepileptic Drugs Market By Distribution Channel
10.5.1.5 Egypt
10.5.1.5.1 Egypt Antiepileptic Drugs Market By Drug Generation
10.5.1.5.2 Egypt Antiepileptic Drugs Market By Distribution Channel
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Antiepileptic Drugs Market By Drug Generation
10.5.1.6.2 Saudi Arabia Antiepileptic Drugs Market By Distribution Channel
10.5.1.7 Qatar
10.5.1.7.1 Qatar Antiepileptic Drugs Market By Drug Generation
10.5.1.7.2 Qatar Antiepileptic Drugs Market By Distribution Channel
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Antiepileptic Drugs Market By Drug Generation
10.5.1.8.2 Rest of Middle East Antiepileptic Drugs Market By Distribution Channel
10.5.2 Africa
10.5.2.1 Africa Antiepileptic Drugs Market by Country
10.5.2.2 Africa Antiepileptic Drugs Market By Drug Generation
10.5.2.3 Africa Antiepileptic Drugs Market By Distribution Channel
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Antiepileptic Drugs Market By Drug Generation
10.5.2.4.2 Nigeria Antiepileptic Drugs Market By Distribution Channel
10.5.2.5 South Africa
10.5.2.5.1 South Africa Antiepileptic Drugs Market By Drug Generation
10.5.2.5.2 South Africa Antiepileptic Drugs Market By Distribution Channel
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Antiepileptic Drugs Market By Drug Generation
10.5.2.6.2 Rest of Africa Antiepileptic Drugs Market By Distribution Channel
10.6 Latin America
10.6.1 Latin America Antiepileptic Drugs Market by Country
10.6.2 Latin America Antiepileptic Drugs Market By Drug Generation
10.6.3 Latin America Antiepileptic Drugs Market By Distribution Channel
10.6.4 Brazil
10.6.4.1 Brazil Antiepileptic Drugs Market By Drug Generation
10.6.4.2 Brazil Africa Antiepileptic Drugs Market By Distribution Channel
10.6.5 Argentina
10.6.5.1 Argentina Antiepileptic Drugs Market By Drug Generation
10.6.5.2 Argentina Antiepileptic Drugs Market By Distribution Channel
10.6.6 Colombia
10.6.6.1 Colombia Antiepileptic Drugs Market By Drug Generation
10.6.6.2 Colombia Antiepileptic Drugs Market By Distribution Channel
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Antiepileptic Drugs Market By Drug Generation
10.6.7.2 Rest of Latin America Antiepileptic Drugs Market By Distribution Channel

11. Company Profile
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Eisai Co., Ltd.
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 AstraZeneca
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Novartis AG
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Abbott
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Pfizer Inc.
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 GlaxoSmithKline plc.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Sanofi.
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 GW Pharmaceuticals Plc.
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View

12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions

13. USE Cases and Best Practices

14. Conclusion